DIA’s Global Annual Meeting
Join Our Team In San Diego
Our evidence development and safety and risk management experts work with biopharma to generate powerful real-world evidence and conduct pharmacovigilance and REMS. Our teams leverage real-world data, generate evidence and insights, and deliver forward-thinking, evidence-based solutions to keep our customers and patients at the forefront of innovative approaches one patient at a time.
Find out how we can help you during DIA this year. We will be highlighting our pharmacovigilance automation and our booth features a live demo of our real-time pharmacovigilance analytics. Be sure to meet our speakers and learn more about our modernized, technology-enabled study design and execution as well!
Meet With Us at DIA
Presentation
RWD Enrichment Studies: Linking Pre- and Post-Trial Data to Inform Product Strategy
Tuesday, June 18, 11:55 AM
Irene Cosmatos, Senior Director, Epidemiology & RWE and Jeff Lowry, Senior Director, Technology Solutions Services
Capturing data on the patient’s healthcare journey prior to and following participation in a clinical trial builds a more complete understanding of their healthcare journey and increases the overall evidence yield. This presentation explores the value and challenges of tokenization and linkage to diverse secondary healthcare data as well as a case study highlighting the real-world application of this approach.
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
Outsourcing in Clinical Trials Southern California 2026
HUB and Specialty Pharmacy West Conference 2026
World Orphan Drug Congress 2026
Meet With Us at DIA
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.